Medication info
Megatelmic Tablets 40/12.5 Milligrams

Megatelmic Tablets 40/12.5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
White or off-white rectangular tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202001518 · Approved 2020.03.04 · Insurance code 060500580

Summary

Main use
Treatment of essential hypertension not adequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg alone. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg alone. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as single-ingredient products, or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with hepatic impairment. Elderly patients No dose adjustment is necessary.
Child dose
Under 18 years of age: The safety and efficacy of this medicine have not been established.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used in the treatment of essential hypertension. It is administered as an adjunct treatment to effectively manage blood pressure in patients whose blood pressure is not sufficiently controlled with telmisartan alone. This helps reduce the risk of cardiovascular complications and improves health.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a beverage, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg alone. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg alone. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as single-ingredient products, or with the combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, 2.). Thiazide diuretics should be administered with caution to patients with hepatic impairment. Elderly patients No dose adjustment is necessary.

Child dose

Under 18 years of age: The safety and efficacy of this medicine have not been established.

Precautions

This medication can pose serious risks to the fetus and newborn if used during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used in individuals with allergic reactions to specific components, in pregnant or breastfeeding women, or in patients with severe liver or kidney disease. Elderly patients or those with elevated potassium levels, liver disease, heart disease, gastrointestinal disease, or renal vascular issues should use this medication cautiously. The hydrochlorothiazide component may cause photosensitivity, so caution is needed when exposed to sunlight, and the risk of skin cancer may increase; therefore, it is important to regularly check skin condition. This medication can cause various side effects, including hypotension, dizziness, headaches, gastrointestinal disturbances, skin rashes, and myalgia, so if symptoms worsen or if unusual reactions are suspected, consult a physician immediately. This medication may interact with other antihypertensive drugs, diuretics, lithium, potassium supplements, etc., so inform your doctor or pharmacist of any other medications you are taking. If planning to become pregnant or during pregnancy, it is recommended to switch to other antihypertensive medications that have established safety. During breastfeeding, this medication may be excreted in breast milk, so it should be avoided and consult your physician if necessary. In case of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, so visit a healthcare facility immediately for appropriate treatment. This medication is not recommended for children under 18 years of age as safety and efficacy have not been established, and in elderly patients, blood pressure reduction should be carefully monitored to avoid excessive hypotension. Store this medication out of reach of children and avoid transferring it to other containers.

Side effects

  • Hypotension
  • decreased skull formation in neonates
  • anuria
  • renal failure
  • oligohydramnios
  • limb spasms
  • craniofacial deformities
  • pulmonary hypoplasia
  • premature birth
  • intrauterine growth restriction
Show 127 more
  • patent ductus arteriosus
  • bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver function abnormalities
  • liver disorders
  • vascular edema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased serum uric acid
  • increased serum creatinine
  • increased creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • pain
  • renal impairment
  • asthenia
  • increased serum creatinine
  • increased serum uric acid
  • increased creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • aplastic anemia
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • jaundice
  • cholestasis
  • photosensitivity reactions
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • erythema multiforme
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal impairment
  • asthenia
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremors
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • pruritus
  • myalgia
  • floating sensation
  • lip and hand tremors
  • sensory hypersensitivity
  • gum disease
  • chapped lips
  • decreased vision
  • hypoglycemia
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; hence, it should be stored in a tightly sealed container. A storage temperature between 1 and 30 degrees Celsius at room temperature is recommended to maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White or off-white rectangular tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.